Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
The respiratory syncytial virus (RSV) causes significant respiratory disease in young infants and the elderly. Immune prophylaxis in infants is currently limited to palivizumab, an anti-RSV fusion (F) protein monoclonal antibody (mAb). While anti-F protein mAbs neutralize RSV, they are unable to pre...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2023-04-01
|
| Serier: | Viruses |
| Fag: | |
| Online adgang: | https://www.mdpi.com/1999-4915/15/5/1067 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
